Aguado, Tania et al. 2006. “The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells.” Journal of Neuroscience 26(5): 1551–61. https://doi: 10.1523/JNEUROSCI.3101-05.2006.
Alexandre, João, Helena Carmo, Félix Carvalho, and João Pedro Silva. 2020. “Synthetic Cannabinoids and Their Impact on Neurodevelopmental Processes.” Addiction Biology 25(2): 1–12.https://doi.org/10.1111/adb.12824wileyonlinelibrary.com/journal/adb.
Almada, Marta, Patrícia Alves, et al. 2020. “Synthetic Cannabinoids JWH-018, JWH-122, UR-144 and the Phytocannabinoid THC Activate Apoptosis in Placental Cells.” Toxicology Letters 319(June 2019): 129–37. https://doi.org/10.1016/j.toxlet.2019.11.004.
Almada, Marta, Lia Costa, et al. 2020. “The Endocannabinoid 2-Arachidonoylglycerol Promotes Endoplasmic Reticulum Stress in Placental Cells.” Reproduction 160(2): 171–80.https://doi.org/10.1530/REP-19-0539.
Amlani, Aarti et al. 2017. “Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor Expression in the Brains of Dams but Not Their Offspring.” Developmental Neuroscience 39(6): 498–506.https://doi.org/10.1159/000480453.
Armstrong, Faith, Michael T. McCurdy, and Mojdeh S. Heavner. 2019. “Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review.” Pharmacotherapy 39(4): 508–13.https://doi.org/10.1002/phar.2241.
Baggelaar, Marc P., Mauro Maccarrone, and Mario van der Stelt. 2018. “2-Arachidonoylglycerol: A Signaling Lipid with Manifold Actions in the Brain.” Progress in Lipid Research 71(November 2017): 1–17. https://doi.org/10.1016/j.plipres.2018.05.002.
Bara, Anissa et al. 2018. “Sex-Dependent Effects of in Utero Cannabinoid Exposure on Cortical Function.” eLife 7: 1–31.https://doi.org/10.7554/eLife.36234.001.
Bari, Monica et al. 2005. “Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells: Implications for Anandamide-Induced Apoptosis.” Journal of Biological Chemistry 280(13): 12212–20.https://doi.org/10.1074/jbc.M411642200.
Baron, Eric P. 2018. “Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.” Headache 58(7): 1139–86.https://doi.org/10.1111/head.13345.
Basavarajappa, Balapal, Ralph Nixon, and Ottavio Arancio. 2009. “Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration.” Mini-Reviews in Medicinal Chemistry 9(4): 448–62. https://doi: 10.2174/138955709787847921.
Bénard, Giovanni et al. 2012. “Mitochondrial CB 1 Receptors Regulate Neuronal Energy Metabolism.” Nature Neuroscience 15(4): 558–64.https://doi.org/10.1038/nn.3053.
Billakota, Santoshi, Orrin Devinsky, and Eric Marsh. 2019. “Cannabinoid Therapy in Epilepsy.” Current Opinion in Neurology 32(2): 220–26. https://doi: 10.1097/WCO.0000000000000660.
Bisogno, Tiziana et al. 2003. “Cloning of the First Sn1-DAG Lipases Points to the Spatial and Temporal Regulation of Endocannabinoid Signaling in the Brain.” Journal of Cell Biology 163(3): 463–68.https://doi.org/10.1083/jcb.200305129.
Blankman, Jacqueline L, Gabriel M Simon, and Benjamin F Cravatt. 2009. “A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.” 14(12): 1347–56.https://doi: 10.1016/j.chembiol.2007.11.006.
Bonini, Sara Anna et al. 2018. “Cannabis Sativa: A Comprehensive Ethnopharmacological Review of a Medicinal Plant with a Long History.” Journal of Ethnopharmacology 227(May): 300–315. https://doi.org/10.1016/j.jep.2018.09.004.
Borrelli, Francesca et al. 2015. “Palmitoylethanolamide, a Naturally Occurring Lipid, Is an Orally Effective Intestinal Anti-Inflammatory Agent.” British Journal of Pharmacology 172(1): 142–58. https:// doi: 10.1111/bph.12907.
Brittis, Perry A., Jerry Silver, Frank S. Walsh, and Patrick Doherty. 1996. “Fibroblast Growth Factor Receptor Function Is Required for the Orderly Projection of Ganglion Cell Axons in the Developing Mammalian Retina.” Molecular and Cellular Neurosciences 8(2–3): 120–28. https://doi:10.1006/mcne.1996.0051.
Brown, A. J. 2007. “Novel Cannabinoid Receptors.” British Journal of Pharmacology 152(5): 567–75.https://doi.org/10.1038/sj.bjp.0707481.
Brown, Qiana L. et al. 2017. “Trends in Marijuana Use among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014.” JAMA - Journal of the American Medical Association 317(2): 207–9. http://doi:10.1001/jama.2016.17383.
Buckley, N. E., S. Hansson, G. Harta, and É Mezey. 1997. “Expression of the CB1 and CB2 Receptor Messenger RNAs during Embryonic Development in the Rat.” Neuroscience 82(4): 1131–49.https://doi.org/10.1016/S0306-4522(97)00348-5.
Busquets-Garcia, Arnau, Jaideep Bains, and Giovanni Marsicano. 2018. “CB 1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity.” Neuropsychopharmacology 43(1): 4–20. http://dx.doi.org/10.1038/npp.2017.206.
Campbell, Veronica A. 2001. “Tetrahydrocannabinol-Induced Apoptosis of Cultured Cortical Neurones Is Associated with Cytochrome c Release and Caspase-3 Activation.” Neuropharmacology 40(5): 702–9.https://doi.org/10.1016/S0028-3908(00)00210-0.
Campos, Alline C. et al. 2017. “Cannabinoids as Regulators of Neural Development and Adult Neurogenesis.” : 117–36. http://link.springer.com/10.1007/978-3-319-49343-5.
Casarejos, Maria J. et al. 2013. “Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy.” Journal of Alzheimer’s Disease 35(3): 525–39. https://doi 10.3233/JAD-130050
Chan, Guy Chiu Kai, Thomas R. Hinds, Soren Impey, and Daniel R. Storm. 1998. “Hippocampal Neurotoxicity of Δ9-Tetrahydrocannabinol.” Journal of Neuroscience 18(14): 5322–32.https://doi.org/10.1523/JNEUROSCI.18-14-05322.1998.
Chen, De Jie et al. 2017. “Brain Cannabinoid Receptor 2: Expression, Function and Modulation.” Acta Pharmacologica Sinica 38(3): 312–16. https://doi: 10.1038/aps.2016.149.
Coke, Christopher J. et al. 2016. “Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.” Journal of Biological Chemistry 291(19): 9991–10005.https://doi.org/10.1074/jbc.M115.712661.
Corsi, Daniel J. et al. 2019. “Trends and Correlates of Cannabis Use in Pregnancy: A Population-Based Study in Ontario, Canada from 2012 to 2017.” Canadian Journal of Public Health 110(1): 76–84.https://doi.org/10.17269/s41997-018-0148-0.
Cortez, Isadora L., Naielly Rodrigues da Silva, Francisco S. Guimarães, and Felipe V. Gomes. 2020. “Are CB2 Receptors a New Target for Schizophrenia Treatment?” Frontiers in Psychiatry 11(October): 1–11. https://doi: 10.3389/fpsyt.2020.587154Schizophrenia.
Costa, L. et al. 2021. “The Major Endocannabinoid Anandamide (AEA) Induces Apoptosis of Human Granulosa Cells.” Prostaglandins Leukotrienes and Essential Fatty Acids 171(February): 102311. https://doi.org/10.1016/j.plefa.2021.102311.
Costa, Lia et al. 2016. “Cannabinoid-Induced Autophagy: Protective or Death Role?” Prostaglandins and Other Lipid Mediators 122: 54–63.https://doi.org/10.1016/j.prostaglandins.2015.12.006.
Cottone, Erika et al. 2021. “Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified in Vitro Model.” Molecules 26(5).https://doi.org/10.3390/molecules26051448.
Cravatt, Benjamin F. et al. 2001. “Supersensitivity to Anandamide and Enhanced Endogenous Cannabinoid Signaling in Mice Lacking Fatty Acid Amide Hydrolase.” Proceedings of the National Academy of Sciences of the United States of America 98(16): 9371–76.https://doi.org/10.1073/pnas.161191698.
Cristino, Luigia, Tiziana Bisogno, and Vincenzo Di Marzo. 2020. “Cannabinoids and the Expanded Endocannabinoid System in Neurological Disorders.” Nature Reviews Neurology 16(1): 9–29. http://dx.doi.org/10.1038/s41582-019-0284-z.
Das, Subhadip et al. 2019. “Cannabinoid Signaling in Cancer.” Advances in Experimental Medicine and Biology 1162: 51–61.https://doi.org/10.1007/978-3-030-21737-2_451.
Drummer, Olaf H., Dimitri Gerostamoulos, and Noel W. Woodford. 2019. “Cannabis as a Cause of Death: A Review.” Forensic Science International 298: 298–306. https://doi.org/10.1016/j.forsciint.2019.03.007.
Dyall, S. C. et al. 2016. “Distinctive Effects of Eicosapentaenoic and Docosahexaenoic Acids in Regulating Neural Stem Cell Fate Are Mediated via Endocannabinoid Signalling Pathways.” Neuropharmacology 107: 387–95. http://dx.doi.org/10.1016/j.neuropharm.2016.03.055.
Fernández-ruiz, Javier et al. 2000. “The endogenous cannabinoid system and brain development.” Tins 23(1). https://doi.org/10.1016/S0166-2236(99)01491-5.
Ferreira, Filipa Fiel et al. 2018. “Brain-Derived Neurotrophic Factor (BDNF) Role in Cannabinoid-Mediated Neurogenesis.” Frontiers in Cellular Neuroscience 12(November): 1–16. https://doi: 10.3389/fncel.2018.00441.
Filomeni, G., D. De Zio, and F. Cecconi. 2015. “Oxidative Stress and Autophagy: The Clash between Damage and Metabolic Needs.” Cell Death and Differentiation 22(3): 377–88. http://dx.doi.org/10.1038/cdd.2014.150.
Flament, Julien, Nathan Scius, and Henri Thonon. 2020. “Cannabinoid Hyperemesis Syndrome in the Pregnant Patient: Clinical Case and Literature Review.” International Journal of Emergency Medicine 13(1): 1–4.https://doi.org/10.1186/s12245-020-00311-y.
Fonseca, B. M. et al. 2010. “The Endocannabinoid 2-Arachidonoylglycerol (2-AG) and Metabolizing Enzymes during Rat Fetoplacental Development: A Role in Uterine Remodelling.” International Journal of Biochemistry and Cell Biology 42(11): 1884–92. http://dx.doi.org/10.1016/j.biocel.2010.08.006.
Fonseca, B. M., G. Correia-da-Silva, and N. A. Teixeira. 2009. “Anandamide-Induced Cell Death: Dual Effects in Primary Rat Decidual Cell Cultures.” Placenta 30(8): 686–92. http://dx.doi.org/10.1016/j.placenta.2009.05.012.
Fonseca, B. M., N. A. Teixeira, and G. Correia-da-Silva. 2017. “Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions.” Reviews of Physiology, Biochemistry and Pharmacology 173: 63–88. https://doi: 10.1007/112_2017_3
Frau, Roberto et al. 2019. “Prenatal THC Exposure Produces a Hyperdopaminergic Phenotype Rescued by Pregnenolone.” Nature Neuroscience 22(12): 1975–85. https://doi:10.1038/s41593-019-0512-2.Prenatal
Freitas, Hércules Rezende et al. 2019. “Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture.” Molecular Neurobiology 56(9): 6472–86.https://doi.org/10.1007/s12035-019-1537-y.
Freund, Tamás F., István Katona, and Daniele Piomelli. 2003. “Role of Endogenous Cannabinoids in Synaptic Signaling.” Physiological Reviews 83(3): 1017–66. http://doi: 10.1152/physrev.00004.2003.
Galluzzi, Lorenzo et al. 2018. “Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018.” Cell Death and Differentiation 25(3): 486–541.https://doi.org/10.1038/s41418-017-0012-4.
Galve-Roperh, Ismael et al. 2002. “Mechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor.” Molecular Pharmacology 62(6): 1385–92.https://doi.org/10.1124/mol.62.6.1385.
———. 2006. “Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development.” Current Pharmaceutical Design 12(18): 2319–25. https://doi:10.2174/138161206777585139
———. 2013. “Cannabinoid Receptor Signaling in Progenitor/Stem Cell Proliferation and Differentiation.” Progress in Lipid Research 52(4): 633–50. http://dx.doi.org/10.1016/j.plipres.2013.05.004.
Garcia-Arencibia, Moises, Eduardo Molina-Holgado, and Francisco Molina-Holgado. 2019. “Effect of Endocannabinoid Signalling on Cell Fate: Life, Death, Differentiation and Proliferation of Brain Cells.” British Journal of Pharmacology 176(10): 1361–69.https://doi.org/10.1111/bph.14369.
García, María del Carmen, Edda Adler-Graschinsky, and Stella Maris Celuch. 2009. “Enhancement of the Hypotensive Effects of Intrathecally Injected Endocannabinoids by the Entourage Compound Palmitoylethanolamide.” European Journal of Pharmacology 610(1–3): 75–80. http://dx.doi.org/10.1016/j.ejphar.2009.03.021.
Giorgetti, Arianna et al. 2020. “Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists.” Frontiers in Psychiatry 11(May): 1–22. https://doi: 10.3389/fpsyt.2020.00464Post-Mortem
Gómez Del Pulgar, Teresa, Guillermo Velasco, and Manuel Guzmán. 2000. “The CB1 Cannabinoid Receptor Is Coupled to the Activation of Protein Kinase B/Akt.” Biochemical Journal 347(2): 369–73. https://doi: 10.1042/0264-6021:3470369
Gomez, Oscar et al. 2015. “A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways.” Journal of Neuroimmune Pharmacology 10(2): 309–17. https://doi: 10.1007/s11481-015-9609-x.
Grant, Kimberly S. et al. 2018. “Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development.” Pharmacology and Therapeutics 182(1): 133–51. https://doi:10.1016/j.pharmthera.2017.08.014.
Gulyas, A. I. et al. 2004. “Segregation of Two Endocannabinoid-Hydrolyzing Enzymes into Pre- and Postsynaptic Compartments in the Rat Hippocampus, Cerebellum and Amygdala.” European Journal of Neuroscience 20(2): 441–58. https://doi: 10.1111/j.1460-9568.2004.03428.x.
Guzmán, Manuel. 2003. “Cannabinoids: Potential Anticancer Agents.” Nature Reviews Cancer 3(10): 745–55. http://www.nature.com/doifinder/10.1038/nrc1188. https://doi:10.1038/nrc1188.
Han, Jing et al. 2012. “Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD.” Cell 148(5): 1039–50. http://dx.doi.org/10.1016/j.cell.2012.01.037.
Hansen, Henrik H. et al. 2008. “Cannabinoids Enhance Susceptibility of Immature Brain to Ethanol Neurotoxicity.” Annals of Neurology 64(1): 42–52.https://doi.org/10.1002/ana.21287.
Hanuš, Lumír O. 2007. “Discovery and Isolation of Anandamide and Other Endocannabinoids.” Chemistry and Biodiversity 4(8): 1828–41.https://doi.org/10.1002/cbdv.200790154.
Harkany, Tibor et al. 2007. “The Emerging Functions of Endocannabinoid Signaling during CNS Development.” Trends in Pharmacological Sciences 28(2): 83–92.https://doi:10.1016/j.tips.2006.12.004.
Harkany, Tibor, Erik Keimpema, Klaudia Barabás, and Jan Mulder. 2008. “Endocannabinoid Functions Controlling Neuronal Specification during Brain Development.” Molecular and Cellular Endocrinology 286(1-2 SUPPL. 1): 84–90. https://doi:10.1016/j.mce.2008.02.011.
Heimann, Andrea S. et al. 2021. “Hemopressin as a Breakthrough for the Cannabinoid Field.” Neuropharmacology 183: 108406. https://doi.org/10.1016/j.neuropharm.2020.108406.
Huestis, Marilyn A. et al. 2019. “Cannabidiol Adverse Effects and Toxicity.” Current Neuropharmacology 17(10): 974–89. https://doi:10.2174/1570159X17666190603171901
Hutch, Chelsea R., and Colleen C. Hegg. 2016. “Cannabinoid Receptor Signaling Induces Proliferation but Not Neurogenesis in the Mouse Olfactory Epithelium.” Neurogenesis 3(1): 1–15. http://dx.doi.org/10.1080/23262133.2015.1118177.
Jiang, Wen et al. 2005. “Cannabinoids Promote Embryonic and Adult Hippocampus Neurogenesis and Produce Anxiolytic- and Antidepressant-like Effects.” Journal of Clinical Investigation 115(11): 3104–16. https://doi:10.1172/JCI25509.
Kaczocha, Martin et al. 2010. “Lipid Droplets Are Novel Sites of N-Acylethanolamine Inactivation by Fatty Acid Amide Hydrolase-2.” Journal of Biological Chemistry 285(4): 2796–2806.https://doi.org/10.1074/jbc.M109.058461.
Kanellopoulos, Jean M., and Cécile Delarasse. 2019. “Pleiotropic Roles of P2X7 in the Central Nervous System.” Frontiers in Cellular Neuroscience 13(September): 1–18. http://doi: 10.3389/fncel.2019.00401
Keimpema, Erik et al. 2010. “Differential Subcellular Recruitment of Monoacylglycerol Lipase Generates Spatial Specificity of 2-Arachidonoyl Glycerol Signaling during Axonal Pathfinding.” Journal of Neuroscience 30(42): 13992–7. https://doi: 10.1523/JNEUROSCI.2126-10.2010.
Kendall, Debra A., and Guillermo A. Yudowski. 2017. “Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease.” Frontiers in Cellular Neuroscience 10(January): 1–10. http://doi: 10.3389/fncel.2016.00294Edited.
Koltai, Hinanit, and Dvora Namdar. 2020. “Cannabis Phytomolecule ‘Entourage’: From Domestication to Medical Use.” Trends in Plant Science 25(10): 976–84. https://doi.org/10.1016/j.tplants.2020.04.007.
Lee, Jong Eun et al. 2011. “Autophagy Regulates Embryonic Survival during Delayed Implantation.” Endocrinology 152(5): 2067–75. https://doi: 10.1210/en.2010-1456.
Leonelli, Mauro, Luiz R.G. Britto, Gabriela P. Chaves, and Andréa S. Torrão. 2005. “Developmental Expression of Cannabinoid Receptors in the Chick Retinotectal System.” Developmental Brain Research 156(2): 176–82.https://doi.org/10.1016/j.devbrainres.2005.02.009.
Levinsohn, Erik A., and Kevin P. Hill. 2020. “Clinical Uses of Cannabis and Cannabinoids in the United States.” Journal of the Neurological Sciences 411(August 2019): 116717. https://doi.org/10.1016/j.jns.2020.116717.
Lojpur, Tina et al. 2019. “Δ9-Tetrahydrocannabinol Leads to Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in Human BeWo Trophoblasts.” Reproductive Toxicology 87(May): 21–31. https://doi.org/10.1016/j.reprotox.2019.04.008.
López-Moreno, José Antonio, Gustavo González-Cuevas, Guillermo Moreno, and Miguel Navarro. 2008. “The Pharmacology of the Endocannabinoid System: Functional and Structural Interactions with Other Neurotransmitter Systems and Their Repercussions in Behavioral Addiction.” Addiction Biology 13(2): 160–87. http://doi:10.1111/j.1369-1600.2008.00105.x.
Lu, Qingjun, Alex Straiker, Qingxian Lu, and Greg Maguire. 2000. “Expression of CB2 Cannabinoid Receptor MRNA in Adult Rat Retina.” Visual Neuroscience 17(1): 91–95.https://doi.org/10.1017/S0952523800171093.
Luo, Huilong et al. 2019. “Cannabidiol Increases Proliferation, Migration, Tubulogenesis, and Integrity of Human Brain Endothelial Cells through TRPV2 Activation.” Molecular Pharmaceutics 16(3): 1312–26. https://doi: 10.1021/acs.molpharmaceut.8b01252.
Maccarrone, Mauro et al. 2015. “Endocannabinoid Signaling at the Periphery: 50 Years after THC.” Trends in Pharmacological Sciences 36(5): 277–96. http://doi:10.1016/j.tips.2015.02.008.
Maccarrone. 2017. “Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years.” Frontiers in Molecular Neuroscience 10(May): 1–10. https://doi: 10.3389/fnmol.2017.00166Metabolism
Maccarrone, Mauro et al. 2014. “Programming of Neural Cells by (Endo)Cannabinoids: From Physiological Rules to Emerging Therapies.” Nature Reviews Neuroscience 15(12): 786–801. http://www.nature.com/articles/nrn3846 (June 20, 2018). https://doi:10.1038/nrn3846.
Mackie, K. 2005. “Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System.” Handbook of Experimental Pharmacology 168: 299–325. https://doi:10.1007/3-540-26573-2_10.
Maia, J., B. M. Fonseca, N. Teixeira, and G. Correia-Da-Silva. 2020. “The Fundamental Role of the Endocannabinoid System in Endometrium and Placenta: Implications in Pathophysiological Aspects of Uterine and Pregnancy Disorders.” Human Reproduction Update 26(4): 586–602. https://doi:10.1093/humupd/dmaa005The
Martínez-Pinilla, E. et al. 2014. “CB1 and GPR55 Receptors Are Co-Expressed and Form Heteromers in Rat and Monkey Striatum.” Experimental Neurology 261: 44–52. http://dx.doi.org/10.1016/j.expneurol.2014.06.017.
Mccoy, Kathleen L. 2016. “Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.” Mediators of Inflammation 2016.http://dx.doi.org/10.1155/2016/5831315.
Miranda, Cláudia C. et al. 2020. “HiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation.” Frontiers in Molecular Neuroscience 13(July): 1–11. https://doi: 10.3389/fnmol.2020.00119.
Molina-Holgado, Eduardo et al. 2002. “Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling.” Journal of Neuroscience 22(22): 9742–53.https://doi.org/10.1523/JNEUROSCI.22-22-09742.2002.
Morales, Paula, and Patricia H. Reggio. 2017. “ An Update on Non-CB 1 , Non-CB 2 Cannabinoid Related G-Protein-Coupled Receptors .” Cannabis and Cannabinoid Research 2(1): 265–73. https://doi: 10.1089/can.2017.0036.
Muccioli, Giulio G. et al. 2007. “Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells.” Journal of Neuroscience 27(11): 2883–89.https://doi.org/10.1523/JNEUROSCI.4830-06.2007.
Muller, Chanté, Paula Morales, and Patricia H. Reggio. 2019. “Cannabinoid Ligands Targeting TRP Channels.” Frontiers in Molecular Neuroscience 11(January): 1–15. https://doi: 10.3389/fnmol.2018.00487Cannabinoid.
Murataeva, N., A. Straiker, and K. MacKie. 2014. “Parsing the Players: 2-Arachidonoylglycerol Synthesis and Degradation in the CNS.” British Journal of Pharmacology 171(6): 1379–91.https://doi: 10.1111/bph.12411.
Navarrete, Francisco et al. 2020. “Cannabis Use in Pregnant and Breastfeeding Women: Behavioral and Neurobiological Consequences.” Frontiers in Psychiatry 11(November): 1–15. https://doi: 10.3389/fpsyt.2020.586447Cannabis.
Notaras, Michael et al. 2021. “Neurodevelopmental Signatures of Narcotic and Neuropsychiatric Risk Factors in 3D Human-Derived Forebrain Organoids.” Molecular Psychiatry (June). http://dx.doi.org/10.1038/s41380-021-01189-9.
Nyilas, Rita et al. 2008. “Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals.” Journal of Neuroscience 28(5): 1058–63.https://doi: 10.1523/JNEUROSCI.5102-07.2008.
O’Sullivan, Saoirse Elizabeth. 2016. “An Update on PPAR Activation by Cannabinoids.” British Journal of Pharmacology 173(12): 1899–1910.https://doi.org/10.1111/bph.13497.
Oh, Hyun Ah et al. 2013. “Uncovering a Role for Endocannabinoid Signaling in Autophagy in Preimplantation Mouse Embryos.” Molecular Human Reproduction 19(2): 93–101.https://doi:10.1093/molehr/gas049.
Pacher, Pal, Natalya M. Kogan, and Raphael Mechoulam. 2020. “Beyond THC and Endocannabinoids.” Annual Review of Pharmacology and Toxicology 60: 637–59.https://doi.org/10.1146/annurev-pharmtox-010818-021441.
Palazuelos, Javier et al. 2012. “CB 2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via MTORC1 Signaling.” Journal of Biological Chemistry 287(2): 1198–1209.https://doi.org/10.1074/jbc.M111.291294.
Paraíso-Luna, Juan et al. 2020. “Endocannabinoid Signalling in Stem Cells and Cerebral Organoids Drives Differentiation to Deep Layer Projection Neurons via CB1 Receptors.” Development (Cambridge) 147(24).https://doi.org/10.1242/dev.192161.
Paria, B. C. et al. 2001. “Dysregulated Cannabinoid Signaling Disrupts Uterine Receptivity for Embryo Implantation.” Journal of Biological Chemistry 276(23): 20523–28.https://doi.org/10.1074/jbc.M100679200.
Parker, Linda A. 2017. Cannabinoids and the Brain Cannabinoids and the Brain.
Peres, Fernanda F. et al. 2018. “Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?” Frontiers in Pharmacology 9(MAY): 1–12. https://doi: 10.3389/fphar.2018.00482Cannabidiol.
Pertwee, R. 2010. “Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists.” Current Medicinal Chemistry 17(14): 1360–81.https://doi: 10.2174/092986710790980050.
Pertwee, Roger G. 2006. “Cannabinoid Pharmacology: The First 66 Years.” British Journal of Pharmacology 147(SUPPL. 1). http://doi: 10.1038/sj.bjp.0706406.
Philippot, Gaëtan et al. 2019. “A Single Δ9-Tetrahydrocannabinol (THC) Dose during Brain Development Affects Markers of Neurotrophy, Oxidative Stress, and Apoptosis.” Frontiers in Pharmacology 10(October): 1–9. http://doi: 10.3389/fphar.2019.01156ª.
Pinho Costa, José Luis G. et al. 2011. “Neurobiology of Cannabis: From the Endocannabinoid System to Cannabis-Related Disorders.” Jornal Brasileiro de Psiquiatria 60(2): 110–22.https://doi.org/10.1590/S0047-20852011000200006.
Piyanova, Anastasia et al. 2013. “Loss of CB1 Receptors Leads to Decreased Cathepsin D Levels and Accelerated Lipofuscin Accumulation in the Hippocampus.” Mechanisms of Ageing and Development 134(9): 391–99. http://dx.doi.org/10.1016/j.mad.2013.08.001.
Prenderville, Jack A., Áine M. Kelly, and Eric J. Downer. 2015. “The Role of Cannabinoids in Adult Neurogenesis.” British Journal of Pharmacology 172(16): 3950–63.https://doi: 10.1111/bph.13186.
Psychoyos, Delphine, Basalingappa Hungund, Thomas Cooper, and Richard H. Finnell. 2008. “A Cannabinoid Analogue of Δ9-Tetrahydrocannabinol Disrupts Neural Development in Chick.” Birth Defects Research Part B - Developmental and Reproductive Toxicology 83(5): 477–88.https://doi.org/10.1002/bdrb.20166.
Redmond, William John et al. 2014. “Ligand Determinants of Fatty Acid Activation of the Pronociceptive Ion Channel TRPA1.” PeerJ 2014(1): 1–20.https://doi: 10.7717/peerj.248.
Reggio, Patricia. 2010. “Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown.” Current Medicinal Chemistry 17(14): 1468–86. http://doi:10.2174/092986710790980005.
Riquelme-Sandoval, Agustín, Caio O. de Sá-Ferreira, Leo M. Miyakoshi, and Cecilia Hedin-Pereira. 2020. “New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling.” Frontiers in Pharmacology 11(December).https://doi: 10.3389/fphar.2020.596572New.
Rodrigues, Rui S. et al. 2017. “Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis.” Frontiers in Pharmacology 8(AUG): 1–26. https://doi: 10.3389/fphar.2017.00516.
Rog, David J., Turo J. Nurmikko, and Carolyn A. Young. 2007. “Oromucosal Δ9-Tetrahydrocannabinol/Cannabidiol for Neuropathic Pain Associated with Multiple Sclerosis: An Uncontrolled, Open-Label, 2-Year Extension Trial.” Clinical Therapeutics 29(9): 2068–79. https:doi: 10.1016/j.clinthera.2007.09.013.
Rueda, Daniel et al. 2002. “The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway.” Journal of Biological Chemistry 277(48): 46645–50.https://doi.org/10.1074/jbc.M206590200.
Russo, Ethan B. 2019. “The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No ‘Strain,’ No Gain.” Frontiers in Plant Science 9(January): 1–8. https://doi: 10.3389/fpls.2018.01969.
Saario, Susanna M. et al. 2005. “Characterization of the Sulfhydryl-Sensitive Site in the Enzyme Responsible for Hydrolysis of 2-Arachidonoyl-Glycerol in Rat Cerebellar Membranes.” Chemistry and Biology 12(6): 649–56. https://doi:10.1016/j.chembiol.2005.04.013.
de Salas-Quiroga, Adán et al. 2020. “Long-Term Hippocampal Interneuronopathy Drives Sex-Dimorphic Spatial Memory Impairment Induced by Prenatal THC Exposure.” Neuropsychopharmacology 45(5): 877–86. http://dx.doi.org/10.1038/s41386-020-0621-3.
De Salas-Quiroga, Adán et al. 2015. “Prenatal Exposure to Cannabinoids Evokes Long-Lasting Functional Alterations by Targeting CB1 Receptors on Developing Cortical Neurons.” Proceedings of the National Academy of Sciences of the United States of America 112(44): 13693–98.https://doi.org/10.1073/pnas.1514962112.
Sarker, K., and I. Maruyama. 2003. “Anandamide Induces Cell Death Independently of Cannabinoid Receptors or Vanilloid Receptor 1: Possible Involvement of Lipid Rafts.” Cellular and Molecular Life Sciences 60(6): 1200–1208.
Sarker, Krishna Pada et al. 2003. “ASK1-P38 MAPK/JNK Signaling Cascade Mediates Anandamide-Induced PC12 Cell Death.” Journal of Neurochemistry 85(1): 50–61.https://doi:10.1046/j.1471-4159.2003.01663.x.
Sarris, Jerome et al. 2020. “Medicinal Cannabis for Psychiatric Disorders: A Clinically-Focused Systematic Review.” BMC Psychiatry 20(1): 1–14.https://doi.org/10.1186/s12888-019-2409-8.
Schwitzer, Thomas et al. 2016. “The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications.” Neural Plasticity 2016.http://dx.doi.org/10.1155/2016/2916732.
Shanks, Kevin G., and George S. Behonick. 2016. “Death after Use of the Synthetic Cannabinoid 5F-AMB.” Forensic Science International 262: e21–24. http://dx.doi.org/10.1016/j.forsciint.2016.03.004.
Shao, Bo Zong et al. 2014. “Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Activation of Autophagy and Inhibiting NLRP3 Inflammasome.” CNS Neuroscience and Therapeutics 20(12): 1021–28. https://doi: 10.1111/cns.12349
Sharir, Haleli, and Mary E. Abood. 2010. “Pharmacological Characterization of GPR55, a Putative Cannabinoid Receptor.” Pharmacology and Therapeutics 126(3): 301–13. https://doi:10.1016/j.pharmthera.2010.02.004.
Shum, Carole et al. 2020. “Δ9-Tetrahydrocannabinol and 2-AG Decreases Neurite Outgrowth and Differentially Affects ERK1/2 and Akt Signaling in HiPSC-Derived Cortical Neurons.” Molecular and Cellular Neuroscience 103(December 2019): 103463. https://doi.org/10.1016/j.mcn.2019.103463.
Siegmund, Sören V. et al. 2005. “Anandamide Induces Necrosis in Primary Hepatic Stellate Cells.” Hepatology 41(5): 1085–95.https://doi.org/10.1002/hep.20667.
da Silva Sampaio, Luzia et al. 2018. “Cannabinoid Receptor Type 1 Expression in the Developing Avian Retina: Morphological and Functional Correlation with the Dopaminergic System.” Frontiers in Cellular Neuroscience 12(March): 1–10. https://doi: 10.3389/fncel.2018.00058.
Solymosi, Katalin, and Attila Kofalvi. 2016. 17 Mini-Reviews in Medicinal Chemistry Cannabis: A Treasure Trove or Pandora’s Box?.https://doi: 10.2174/13895575166661610041621 33.
Stanslowsky, Nancy et al. 2017. “Functional Effects of Cannabinoids during Dopaminergic Specification of Human Neural Precursors Derived from Induced Pluripotent Stem Cells.” Addiction Biology 22(5): 1329–42.https://doi.org/10.1111/adb.12394.
Stott, C. G. et al. 2013. “A Phase i Study to Assess the Single and Multiple Dose Pharmacokinetics of THC/CBD Oromucosal Spray.” European Journal of Clinical Pharmacology 69(5): 1135–47.https://doi: 10.1007/s00228-012-1441-0.
Sugiura, Takayuki et al. 1996. “2-Arachidonylglycerol, a Putative Endogenous Cannabinoid Receptor Ligand, Induces Rapid, Transient Elevation of Intracellular Free Ca2+ Neuroblastoma X Glioma Hybrid NG108-15 Cells.” Biochemical and Biophysical Research Communications 229(1): 58–64.https://doi.org/10.1006/bbrc.1996.1757.
Taylor, Lesley et al. 2018. “A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.” CNS Drugs 32(11): 1053–67. https://doi.org/10.1007/s40263-018-0578-5.
Tayo, Bola, Lesley Taylor, Farhad Sahebkar, and Gilmour Morrison. 2020. “A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment.” Clinical Pharmacokinetics 59(6): 747–55. https://doi.org/10.1007/s40262-019-00841-6.
Tomiyama, Ken ichi, and Masahiko Funada. 2014. “Cytotoxicity of Synthetic Cannabinoids on Primary Neuronal Cells of the Forebrain: The Involvement of Cannabinoid CB1 Receptors and Apoptotic Cell Death.” Toxicology and Applied Pharmacology 274(1): 17–23. http://dx.doi.org/10.1016/j.taap.2013.10.028.
Tomiyama, Kenichi, and Masahiko Funada. 2011. “Cytotoxicity of Synthetic Cannabinoids Found in ‘Spice’ Products: The Role of Cannabinoid Receptors and the Caspase Cascade in the NG 108-15 Cell Line.” Toxicology Letters 207(1): 12–17. http://dx.doi.org/10.1016/j.toxlet.2011.08.021.
Trabucco, E. et al. 2009. “Endocannabinoid System in First Trimester Placenta: Low FAAH and High CB1 Expression Characterize Spontaneous Miscarriage.” Placenta 30(6): 516–22. http://dx.doi.org/10.1016/j.placenta.2009.03.015.
Trazzi, Stefania et al. 2010. “CB1 Cannabinoid Receptors Increase Neuronal Precursor Proliferation through AKT/Glycogen Synthase Kinase-3β/β-Catenin Signaling.” Journal of Biological Chemistry 285(13): 10098–109.https://doi.org/10.1074/jbc.M109.043711.
Tsuboi, Kazuhito, Toru Uyama, Yasuo Okamoto, and Natsuo Ueda. 2018. “Endocannabinoids and Related N-Acylethanolamines: Biological Activities and Metabolism Makoto Murakami.” Inflammation and Regeneration 38(1): 1–10.https://doi.org/10.1186/s41232-018-0086-5.
Turu, Gábor, and László Hunyady. 2010. “Signal Transduction of the CB1 Cannabinoid Receptor.” Journal of Molecular Endocrinology 44(2): 75–85.https://doi.org/10.1677/JME-08-0190
Ueda, Natsuo, Kazuhito Tsuboi, and Toru Uyama. 2013. “Metabolism of Endocannabinoids and Related N-Acylethanolamines: Canonical and Alternative Pathways.” FEBS Journal 280(9): 1874–94. https://doi:10.1111/febs.12152.
Vargish, G. A. et al. 2017. “Persistent Inhibitory Circuit Defects and Disrupted Social Behaviour Following in Utero Exogenous Cannabinoid Exposure.” Molecular Psychiatry 22(1): 56–67. https://doi:10.1038/mp.2016.17.
Viñals, Xavier et al. 2015. “Cognitive Impairment Induced by Delta9- Tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.” PLoS Biology 13(7): 1–40. https://doi:10.1371/journal.pbio.1002194.
Wang, Haibin et al. 2007. “Differential Regulation of Endocannabinoid Synthesis and Degradation in the Uterus during Embryo Implantation.” Prostaglandins and Other Lipid Mediators 83(1–2): 62–74. https://doi:10.1016/j.prostaglandins.2006.09.009.
Wei, Binqing Q. et al. 2006. “A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals.” Journal of Biological Chemistry 281(48): 36569–78.https://doi.org/10.1074/jbc.M606646200.
Witting, Anke et al. 2004. “P2X7 Receptors Control 2-Arachidonoylglycerol Production by Microglial Cells.” Proceedings of the National Academy of Sciences of the United States of America 101(9): 3214–19. https://doi:10.1073/pnas.0306707101.
Xapelli, Sara et al. 2013. “Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures.” PLoS ONE 8(5). https://doi:10.1371/journal.pone.0063529.
Yazulla, S. 2010. “Retinal Cannabinoids.” Encyclopedia of the Eye (July 2016): 45–53.http://dx.doi.org/10.1016/B978-0-12-809324-5.01504-2.
Young-Wolff, Kelly C. et al. 2017. “Trends in Self-Reported and Biochemically Tested Marijuana Use among Pregnant Females in California from 2009-2016.” JAMA - Journal of the American Medical Association 318(24): 2490–91. https://doi:10.1001/jama.2017.17225.
Zou, Shenglong, and Ujendra Kumar. 2018. “Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.” International Journal of Molecular Sciences 19(3). https://doi:10.3390/ijms19030833.
Zou, Shenglong, Rishi K. Somvanshi, and Ujendra Kumar. 2017. “Somatostatin Receptor 5 Is a Prominent Regulator of Signaling Pathways in Cells with Coexpression of Cannabinoid Receptors 1.” Neuroscience 340(November): 218–31. http://dx.doi.org/10.1016/j.neuroscience.2016.10.056.
Zurolo, E. et al. 2010. “CB1 and CB2 Cannabinoid Receptor Expression during Development and in Epileptogenic Developmental Pathologies.” Neuroscience 170(1): 28–41. http://dx.doi.org/10.1016/j.neuroscience.2010.07.004.